Evidence map›Paper›PMID 32850947›Full record

ArticleFrontiers in molecular biosciences2020

FLCN Regulates HIF2α Nuclear Import and Proliferation of Clear Cell Renal Cell Carcinoma.

Xuyang Zhao, Yadong Ma, Jie Cui, Haiyang Zhao, Lei Liu, Yueyuan Wang, Pengxiang Min, Lin Zhang, Yongchang Chen, Jun Du and 2 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in molecular biosciences, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.3field-weighted citation impact, top 50% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 1 country.

Xuyang ZhaoDepartment of Biochemistry and Molecular Biology, Nanjing Medical University, Nanjing, China.
Yadong MaDepartment of Physiology, Nanjing Medical University, Nanjing, China.
Jie CuiDepartment of Physiology, Xuzhou Medical University, Xuzhou, China.
Haiyang ZhaoState Key Laboratory of Reproductive Medicine, Department of Anatomy, Histology and Embryology, Nanjing Medical University, Nanjing, China.
Lei LiuDepartment of Physiology, Xuzhou Medical University, Xuzhou, China.
Yueyuan WangDepartment of Physiology, Nanjing Medical University, Nanjing, China.
Pengxiang MinDepartment of Physiology, Nanjing Medical University, Nanjing, China.
Lin ZhangDepartment of Physiology, Xuzhou Medical University, Xuzhou, China.
Yongchang ChenDepartment of Physiology, Jiangsu University, Zhenjiang, China.
Jun DuJiangsu Key Laboratory of Cancer Biomarkers, Prevention and Treatment, Collaborative Innovation Center for Cancer Personalized Medicine, Nanjing Medical University, Nanjing, China.
Yujie ZhangJiangsu Key Laboratory of Cancer Biomarkers, Prevention and Treatment, Collaborative Innovation Center for Cancer Personalized Medicine, Nanjing Medical University, Nanjing, China.
Luo GuDepartment of Biochemistry and Molecular Biology, Nanjing Medical University, Nanjing, China.
Nanjing Medical University · CNXuzhou Medical College · CNJiangsu University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

cell proliferationFLCNHIF2αmTORC2nuclear import

Identifiers

PMID32850947
PMCPMC7399043
OpenAlexW3046091303

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.